<div id="readability-page-1"><div><p><span>Burnett Patrick Vice President of Arcutis Biotherapeutics Inc [ARQT] filed a Form 4 on December 17, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:</span></p><div><table><tbody><tr><th><span>Date</span></th><th><span>Transaction</span></th><th><span>Shares</span></th><th><span>Price</span></th><th><span>Value</span></th></tr><tr><td><span>12/15/25</span></td><td><span>Planned Exercise(1)(2)</span></td><td><span>11,500</span></td><td><span>$3.64</span></td><td><span>$41,860</span></td></tr><tr><td><span>12/15/25</span></td><td><span>Planned Sale(2)</span></td><td><span>11,500</span></td><td><span>$28.94</span></td><td><span>$332,851</span></td></tr></tbody></table></div><p><span>Ending Holdings: 98,307 - Direct</span></p><div><table><tbody><tr><td><span>(1)</span></td><td><span>Exercised 8.1 years before expiration date.</span></td></tr><tr><td><span>(2)</span></td><td><span>Executed pursuant to a prearranged trading plan (10b5-1).</span></td></tr></tbody></table></div><p><span>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.</span></p><p><span>Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.</span></p><span> </span></div></div>

ARQT

<p>VP Burnett of Arcutis Biotherapeutics Inc sold 11,500 shares for $332,851, as disclosed in a Form 4 filed with the SEC. The transaction was part of a prearranged trading plan (10b5-1). Ending holdings are 98,307 shares. The Washington Service provides insider trading analysis and data services.</p>

VP Burnett Sells 11,500 ($332.9K) Of Arcutis Biotherapeutics Inc [ARQT]